UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

________________________________________

FORM 10-Q



S     QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934



For the quarterly period ended June 30, 2013



£     TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934



Commission File No. 333-120507



KENERGY SCIENTIFIC, INC.

(Exact name of the Registrant)



|New Jersey               | 20-1862816                 
|------------------------ | ---------------------------
|(State of Incorporation) | (I.R.S. Employer ID Number)



|30 Eglinton Ave W, Suite 808, Mississauga, Ontario, Canada, | M5H 2W9   
|----------------------------------------------------------- | ----------
|(Address of Principal Executive Offices)                    | (Zip Code)



866-520-2370

(Registrant’s Telephone No. including
Area Code)



Indicate
by checkmark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such
reports), and (2) has been subject to such filing requirements for the past 90 days.Yes  S   No  £



Indicate
by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such
shorter period that the registrant was required to submit and post such files).Yes  £ No  S



Indicate by checkmark whether the
registrant is a shell company (as defined in Rule 12b-2 of the Securities Act).   Yes  £ No S



Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated
filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check
one):



|Large
accelerated filer£ | Accelerated filer £ | Non-accelerated
filer£                        | Smaller reporting company S
|------------------------ | ------------------- | --------------------------------------------- | ---------------------------
|                         |                     | (Do not check if a smaller reporting company) |                            





Indicate the number of shares outstanding of the issuer's
common stock, as of the latest practical date:



62,270 shares outstanding of Preferred Stock, par value $1.00 per
share; 5,217,475,719 shares outstanding of Class A Common Stock, no par value and 10,000 shares outstanding of Class B Common Stock,
par value $.01 per share, as of September 1, 2013.
















KENERGY SCIENTIFIC, INC.

TABLE OF CONTENTS







|        | Part I – Financial Information                                                                        | Page 
|------- | ----------------------------------------------------------------------------------------------------- | -----
|        |                                                                                                       |      
|Item 1. | Condensed Financial Statements                                                                        | 4    
|        |                                                                                                       |      
|        | Condensed Balance Sheets – June 30, 2013 and
        December 31, 2012                                | 4    
|        |                                                                                                       |      
|        | Condensed Statements of Operations – Six months and
        three months Ended June 30, 2013 and 2012 | 5    
|        |                                                                                                       |      
|        | Condensed Statements of Operations – Six months
        Ended June 30, 2013 and 2012                  | 6-7  
|        |                                                                                                       |      
|        | Notes to Condensed Financial Statements                                                               | 8-28 
|        |                                                                                                       |      
|Item 2. | Management’s Discussion and Analysis of Financial Position
        And Results of Operations          | 29-31
|        |                                                                                                       |      
|Item 4. | Controls and Procedures                                                                               | 32   
|        |                                                                                                       |      
|        | Part II – Other Information                                                                           |      
|        |                                                                                                       |      
|Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds                                           | 33   
|        |                                                                                                       |      
|Item 3. | Defaults Upon Senior Securities                                                                       | 33   
|        |                                                                                                       |      
|Item 6. | Exhibits                                                                                              | 33   





2







EXPLANATORY NOTE



These Financial Statements are part of the Quarterly
Report on Form 10-Q for the three months ended June 30, 2013 do not contain financial statements audited or reviewed by an independent
registered public accounting firm for the six months ended June 30, 2013 and 2012, three months ended June 30, 2013 and 2012 or
the year ended December 31, 2012.













































3





Part 1. Financial Statements



Item 1 - Financial Statements



KENERGY SCIENTIFIC, INC.

CONDENSED BALANCE SHEETS







|                                                                                                                                                    |  | June
    30, |             |   | December
31, |  
|--------------------------------------------------------------------------------------------------------------------------------------------------- |  | ------------ | ----------- | - | ------------ | -
|                                                                                                                                                    |  | 2013         |             |   | 2012         |  
|                                                                                                                                                    |  | (Unaudited)  |             |   | (Unaudited)  |  
|ASSETS                                                                                                                                              |  |              |             |   |              |  
|                                                                                                                                                    |  |              |             |   |              |  
|Current assets:                                                                                                                                     |  |              |             |   |              |  
|Cash and cash equivalents                                                                                                                           |  | $            | 22          |   |              | $
|Accounts receivable, net of allowance for doubtful accounts of $3,479                                                                               |  |              | –           |   |              |  
|Inventory                                                                                                                                           |  |              | 124         |   |              |  
|Prepaid and other current assets                                                                                                                    |  |              | 7,622       |   |              |  
|Total current assets                                                                                                                                |  |              | 7,768       |   |              |  
|Property and equipment, net                                                                                                                         |  |              | 7,757       |   |              |  
|Intangible assets, net and security deposits                                                                                                        |  |              | 131,355     |   |              |  
|                                                                                                                                                    |  |              |             |   |              |  
|Total assets                                                                                                                                        |  | $            | 146,880     |   |              | $
|                                                                                                                                                    |  |              |             |   |              |  
|LIABILITIES & STOCKHOLDERS’ DEFICIT                                                                                                                 |  |              |             |   |              |  
|Current liabilities:                                                                                                                                |  |              |             |   |              |  
|Accounts payable and accrued expenses                                                                                                               |  | $            | 908,838     |   |              | $
|Due to related parties                                                                                                                              |  |              | 107,731     |   |              |  
|Promissory note due to related parties                                                                                                              |  |              | 75,000      |   |              |  
|Promissory note due                                                                                                                                 |  |              | 186,600     |   |              |  
|Convertible promissory note, net of unamortized debt discount of $0 and $2,802, respectively                                                        |  |              | 180,000     |   |              |  
|Convertible debentures, net of unamortized debt discount of $19,845 and $33,605, respectively                                                       |  |              | 1,279,598   |   |              |  
|Derivative liabilities                                                                                                                              |  |              | 1,136,519   |   |              |  
|Total current liabilities                                                                                                                           |  |              | 3,874,286   |   |              |  
|                                                                                                                                                    |  |              |             |   |              |  
|Stockholders' deficit:                                                                                                                              |  |              |             |   |              |  
|Preferred stock, $1.00 par value; authorized 1,000,000 shares; 62,270 and 75,000 issued and outstanding, respectively                               |  |              | 62,270      |   |              |  
|Common stock:                                                                                                                                       |  |              |             |   |              |  
|Class A – no par value; authorized 10,000,000,000 shares; 5,217,475,719 and 1,480,028,558 shares issued and outstanding, respectively (see note 11) |  |              | 12,469,000  |   |              |  
|Class B - $.01 par value; authorized 50,000,000 Shares; 10,000 shares issued and outstanding                                                        |  |              | 100         |   |              |  
|Class C - $.01 par value; authorized 20,000,000 Shares; no shares issued and outstanding                                                            |  |              | –           |   |              |  
|Additional paid-in capital                                                                                                                          |  |              | 1,922,205   |   |              |  
|Accumulated deficit                                                                                                                                 |  |              | (18,180,981 | ) |              |  
|Total stockholders' deficit                                                                                                                         |  |              | (3,727,406  | ) |              |  
|                                                                                                                                                    |  |              |             |   |              |  
|Total liabilities and stockholders' deficit                                                                                                         |  | $            | 146,880     |   |              | $



See accompanying notes to condensed financial
statements

4











KENERGY SCIENTIFIC, INC.

CONDENSED STATEMENTS OF OPERATIONS

(Unaudited)



|                                                  |  | Six months ended |                |   | Three months ended |  
|------------------------------------------------- |  | ---------------- | -------------- | - | ------------------ | -
|                                                  |  | June 30, 2013    |                |   | June 30, 2012      |  
|                                                  |  |                  |                |   |                    |  
|Net sales                                         |  | $                | 8,052          |   |                    | $
|Cost of sales                                     |  |                  | 7,582          |   |                    |  
|                                                  |  |                  |                |   |                    |  
|Gross margin (loss)                               |  |                  | 470            |   |                    |  
|                                                  |  |                  |                |   |                    |  
|Operating expenses:                               |  |                  |                |   |                    |  
|General and administrative expenses               |  |                  | 217,433        |   |                    |  
|Depreciation and amortization                     |  |                  | 18,026         |   |                    |  
|                                                  |  |                  |                |   |                    |  
|Total operating expenses                          |  |                  | 235,459        |   |                    |  
|                                                  |  |                  |                |   |                    |  
|Loss from operations                              |  |                  | (234,989       | ) |                    |  
|                                                  |  |                  |                |   |                    |  
|Other income (expense):                           |  |                  |                |   |                    |  
|Interest expense                                  |  |                  | (415,126       | ) |                    |  
|Other income                                      |  |                  | 17,090         |   |                    |  
|Amortization of debt discount                     |  |                  | (61,082        | ) |                    |  
|Gain (loss) on valuation of derivative            |  |                  | 3,298,434      |   |                    |  
|                                                  |  |                  |                |   |                    |  
|Total other income (expense)                      |  |                  | 2,839,316      |   |                    |  
|                                                  |  |                  |                |   |                    |  
|Income (loss) from operations before Income taxes |  |                  | 2,604,327      |   |                    |  
|                                                  |  |                  |                |   |                    |  
|Provision for income taxes                        |  |                  | –              |   |                    |  
|                                                  |  |                  |                |   |                    |  
|Net income (loss) attributable to common Shares   |  | $                | 2,604,327      |   |                    | $
|                                                  |  |                  |                |   |                    |  
|Basic income (loss) per common share              |  | $                | 0.00           |   |                    | $
|Diluted income (loss) per common share            |  | $                | 0.00           |   |                    | $
|                                                  |  |                  |                |   |                    |  
|Weighted average shares outstanding -             |  |                  |                |   |                    |  
|Basic (see note 5)                                |  |                  | 2,613,517,549  |   |                    |  
|Diluted (see note 5)                              |  |                  | 10,000,000,000 |   |                    |  





See accompanying notes to condensed financial
statements





5









KENERGY SCIENTIFIC, INC.

CONDENSED STATEMENTS OF CASH FLOWS

(Unaudited)



|                                                                                                   |  | Six months Ended |           
|-------------------------------------------------------------------------------------------------- |  | ---------------- | ----------
|                                                                                                   |  | June 30, 2012    |           
|Cash flows from operating activities:                                                              |  |                  |           
|Net income (loss)                                                                                  |  | $                | 2,604,327 
|Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: |  |                  |           
|Amortization of intangibles and depreciation expense                                               |  |                  | 18,026    
|(Gain) loss on valuation of derivative                                                             |  |                  | (3,298,434
|Amortization of debt discount                                                                      |  |                  | 61,082    
|Beneficial interest on conversion of debt                                                          |  |                  | 355,433   
|Imputed interest on related party debt                                                             |  |                  | 2,325     
|(Gain) on disposal of intangible assets                                                            |  |                  | (17,090   
|Changes in assets and liabilities:                                                                 |  |                  |           
|Decrease in accounts receivable                                                                    |  |                  | 61        
|Decrease in inventories                                                                            |  |                  | 82,845    
|Decrease in prepaid expenses                                                                       |  |                  | 4,671     
|Increase in accounts payable and accrued Liabilities                                               |  |                  | 64,782    
|Increase in amounts due to related parties                                                         |  |                  | 71,165    
|Net cash (used in) operating activities                                                            |  |                  | (50,807   
|                                                                                                   |  |                  |           
|Cash flows from investing activities:                                                              |  |                  |           
|Purchase of intangible assets                                                                      |  |                  | –         
|Net cash (used in) investing activities                                                            |  |                  | –         
|                                                                                                   |  |                  |           
|Cash flows from financing activities:                                                              |  |                  |           
|Issuance of promissory notes                                                                       |  |                  | 50,000    
|Net cash provided by financing activities                                                          |  |                  | 50,000    
|                                                                                                   |  |                  |           
|Net (decrease) in cash and cash equivalents                                                        |  |                  | (807      
|                                                                                                   |  |                  |           
|Cash and cash equivalents at beginning of period                                                   |  |                  | 829       
|                                                                                                   |  |                  |           
|Cash and cash equivalents at end of period                                                         |  | $                | 22        
|                                                                                                   |  |                  |           
|SUPPLEMENTAL CASH FLOW INFORMATION:                                                                |  |                  |           
|Taxes paid                                                                                         |  | $                | –         
|Interest paid                                                                                      |  | $                | –         





See accompanying notes to condensed financial statements





6











KENERGY SCIENTIFIC, INC.

CONDENSED STATEMENTS OF CASH FLOWS (Continued)



Supplemental Schedule of Non-Cash Financing Activities:



|For the six months ended June 30, 2013:
|---------------------------------------
|a)                                     
|b)                                     
|c)                                     
|d)                                     
|e)                                     
|f)                                     
|g)                                     
|h)                                     



|For the six months ended June 30, 2012:
|---------------------------------------
|a)                                     
|b)                                     
|c)                                     
|d)                                     



See accompanying
notes to condensed financial statements

7





KENERGY SCIENTIFIC, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2013 and 2012



Note 1        Background



In September 2004, the Board of Directors
of iVoice, Inc., the former parent of the Company, resolved to pursue the separation of iVoice software business into three publicly
owned companies. SpeechSwitch, Inc. (“SpeechSwitch” or “Company”) was incorporated under the laws of New
Jersey on November 10, 2004 as a wholly owned subsidiary of iVoice, Inc. ("iVoice"). The Company received by assignment
all of the interests in and rights and title to, and assumed all of the obligations of, all of the agreements, contracts, understandings
and other instruments of iVoice Technology 3, Inc., a Nevada corporation and affiliate of the Company.



On August 4, 2005, the Company received
notice from the SEC that the registration statement to effectuate the spin-off of the SpeechSwitch from iVoice was declared effective
and the Company immediately embarked on the process to spin off the SpeechSwitch from iVoice.



On August 5, 2005, the spin-off transaction
was accomplished, by the assignment, contribution and conveyance of certain intellectual property, representing the software codes
of speech recognition, and certain accrued liabilities and related party debt into SpeechSwitch (the "Spin-off"). The
Class A Common Stock shares of the Company were distributed to iVoice shareholders in the form of a taxable special dividend distribution.



In June 2009 Kenneth P. Glynn acquired debt
owed by SpeechSwitch, Inc. to third party creditors and the company moved its headquarters from Matawan, NJ to Flemington, NJ.



On February 3, 2011, the Company changed its
name to Kenergy Scientific, Inc.



In November 2011, the Company opened its first
company-owned GreenSmart Store at the Flemington Marketplace in Flemington, NJ.



On February 4, 2013, the Company announced
that they would be closing their GreenSmart store and “would seek a new business entity acquisition to change its direction
and its financial status”. On March 1, 2013, the Company announced that they had closed the GreenSmart store and the goods
and contents were sold out at a 60% discount to loyal customers and debtors for a reduction of some debts.



On June 26, 2013, Kenneth Glynn executed a
non-binding Letter of Intent with Mira Mar Group Inc (“MMG”) that sets forth the general terms and conditions of an
agreement for MMG to purchase shares of stock in Kenergy Scientific, Inc. to acquire control of KNSC for the purpose of operating
two separate subsidiaries. One subsidiary is an EU and (Seychelles in transition) based financial services type organization Pan
Tuffa Holdings which operates and maintains a substantial size of operation of Internet based properties such as (SPOTFX) www.spotfx.com
(OPTIONS) www.optionese.com and (PRECIOUS METALS DEALER) www.trustvault.com. The second subsidiary will be a Canadian based advertising
media company, currently named Sparx Business Media. The media company represents or acts as a sales agent with other advertising
aggregators for approximately 140 Nationwide radio stations in Canada and markets such as Toronto Ottawa and Vancouver. The company
manages social media networks for companies and offers various customer service solutions for their corporate clients through a
company owned call centre. The media group also acts as a sales agent for a Delaware USA real estate timeshare and fractional ownership
company. MMG has no desire to operate the GreenSmart Store business or retain currently existing KNSC Management, Patents and Patent
Applications.

8







On July 26, 2013, the Company terminated merger
discussions with PanTuffa Group and accepted the resignation of Charles Zein as President-Elect of Kenergy.



Note 2        Business
Operations



In June 2009, we entered into fields of development
of various products relating to solar power generating systems; portable solar powered products, such as cell phone and PDA rechargers
that are solar rechargeable; solar rechargeable lantern/flashlight devices; solar backpack rechargers; solar power audio devices,
such as radios; wind power generating systems; and, creative products based on proprietary positions, especially in the area of
healthcare.



On or about July 1 2013 the Company commenced
development of a wholly owned media company under the brand name Sparx Business Media. The Company will earn licensing revenue
from Sparx.



OUR STRATEGY FOR GROWTH MAY INCLUDE JOINT VENTURES,
STRATEGIC ALLIANCES AND MERGERS AND ACQUISITIONS, WHICH COULD BE DIFFICULT TO MANAGE.



The successful execution of the our growth
strategy may depend on many factors, including identifying suitable companies, negotiating acceptable terms, successfully consummating
the corporate relationships and obtaining the required financing on acceptable terms. We may be exposed to risks that we may incorrectly
assess new businesses and technologies. We could face difficulties and unexpected costs during and after the establishment of corporate
relationships.



Acquisitions may be foreign acquisitions which
would add additional risks including political, regulatory and economic risks related to specific countries as well as currency
risks.



The documented difficulties with our transfer
agent coupled with the hostile creditors are making daily on- going operations next to impossible for the new management. The Company
is in talks with bankruptcy trustees and is considering seeking relief under Chapter 11.



Products and Services



The following description of our business is
intended to provide an understanding of our product and the direction of our initial marketing strategy. As the new product development
is in its early development stages, any focus described in the following pages may change and different initiatives may be pursued,
at the discretion of Management. Our areas of development and recent activities include:



|(a) | On June 18, 2009, the Company acquired rights and ownership from GlynnTech, Inc. of technology and pending patent applications relating to cancer treatment drug delivery systems, and the technology transfer into the Company included a prototype, numerous variations on designs, CAD drawings, pending patent applications, risk analysis studies, development history and presentation documents.  The sale was “at cost” of GlynnTech, Inc. in the amount of $182,600.00.  The Agreement called for the aggregate purchase price to be in various denominations of one-year notes. The business objective was to transfer a potentially significant profit opportunity from GlynnTech, Inc. to Kenergy Scientific, Inc.  Three presentations had previously been made to pharmaceutical industry candidates and feedback indicated a high level of interest in potential purchase of this technology following FDA approval of this product.
|--- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

9







|(b) | In solar power energy production systems, the Company is reviewing numerous models of solar photovoltaic panels and converters, as well as unique aftermarket opportunities.  The Company intends to partner with installers and market home, office and commercial solar panels through various media.
|--- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|(c) | In the wind power energy production systems, third party companies will review various microturbine products to license and sell.                                                                                                                                                                      



Product Development



We currently have significant long term plans
to engage in future research and development, to create valuable intellectual property rights and/or to launch new products. The
Company will acquire third party patent rights, develop its own patent rights and evolve both new product and intellectual property
transfer (sale or license) opportunities.



Business Development



Business development objectives at the Company
will be to focus on the primary functions as listed below:



|1. | Continuously develop product ideas, manufacturing and supply alliances;                           
|-- | --------------------------------------------------------------------------------------------------
|2. | Expand sales opportunities through diverse resources;                                             
|3. | Create a continuous flow of ideas and inventions to develop patent and/or new product opportunity;



Strategic Alliances



Kenergy Scientific’s business development
efforts will seek to engage and secure strategic alliances with alternative energy related businesses and professional organizations
in order to develop marketing programs that will expand market share for our products and develop brand recognition by entering
into strategic alliances with companies that offer these products and/or services, the Company will accelerate its entry into various
markets, while eliminating or reducing various training, learning curve, employee and overhead costs.



Sales and Marketing



In November 2011, the Company opened its first
company-owned GreenSmart retail store. On March 1, 2013, the Company announced that they had closed the GreenSmart store and the
goods and contents were sold out at a 60% discount to loyal customers and debtors for a reduction of some debts. There are currently
no plans to develop new retail stores in the future.



Intellectual Property Rights



The Company has completed the acquisition of
the patented rights for the cancer treatment patent awarded by the United States Patent and Trademark Office. No foreign counterparts
have been filed at this time.



Also, the company now has numerous patent applications
and some issued patents in the fields of microturbine, wind power generators, third generation solar power generators, solar desalination,
solar-wind hybrid power generators, biodegradable bandages and other energy and healthcare related inventions.



10







Kenergy Scientific’s Management



On June 30, 2013, Kenneth Glynn resigned from his
positions at Kenergy Scientific, Inc., including President and Chairman of the Board, Ken Moser has simultaneously resigned from
the Board of Directors.





The following individuals were elected to the Board of Directors
effective June 30, 2013



| | · | Zoran Cvetojevic Chairman of the Board
| | - | --------------------------------------

| | · | Jelena Cvetojevic
| | - | -----------------

| | · | Hugo Rubio (Subsequently resigned on September 13, 2013)
| | - | --------------------------------------------------------

| | · | Andrea Zecevic (Subsequently resigned on September 13, 2013)
| | - | ------------------------------------------------------------



The following individuals were elected as Directors
and Officers effective June 30, 2013



| | · | Charles Zein President (Subsequently resigned on July 26, 2013)
| | - | ---------------------------------------------------------------

| | · | Manuel Canales CEO / COO (Subsequently terminated on September 13,
2013)
| | - | ------------------------------------------------------------------------

| | · | Teresa Rubio Secretary and Treasurer (Subsequently resigned on July
4, 2013)
| | - | ----------------------------------------------------------------------------





Note 3        Going
Concern



The accompanying financial statements have
been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplates continuation
of the Company as a going concern.



For the six months ended June 30, 2013, the
Company had a negative cash flow from operations, negative working capital and a loss from operations. These matters raise substantial
doubt about the Company's ability to continue as a going concern. Therefore, recoverability of a major portion of the recorded
asset amounts shown in the accompanying balance sheets is dependent upon continued operations of the Company, which in turn, is
dependent upon the Company's ability to raise capital and/or generate positive cash flow from operations.



The Company will need additional funds to implement
our business plan as our business model requires significant capital expenditures. We will need substantially more capital to execute
our business plan. Our future capital requirements will depend on a number of factors, including our ability to grow our revenues
and manage our business. Our growth will depend upon our ability to raise additional capital, possibly through the issuance of
long-term or short-term indebtedness or the issuance of our equity securities in private or public transactions. If we are successful
in raising equity capital, because of the number and variability of factors that will determine our use of the capital, our ultimate
use of the proceeds may vary substantially from our current plans. We expect that our management will have considerable discretion
over the use of equity proceeds.



Note 4        Summary
of Significant Accounting Policies



a)    Basis of Presentation



The accompanying condensed unaudited interim
financial statements included herein have been prepared, without audit, pursuant to the rules and regulations of the Securities
and Exchange Commission ("SEC"). The condensed financial statements and notes are presented as permitted on Form 10-Q
and do not contain information included in the Company's annual statements and notes. Certain information and footnote disclosures
normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States
of America have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures
are adequate to make the information presented not misleading. It is suggested that these condensed financial statements be read
in conjunction with the December 31, 2012 unaudited financial statements and the accompanying notes thereto. The financial statements
that were reported in the Company’s Form 10-K for the fiscal year ended December 31, 2012 do not contain audited financial
statements audited by an independent registered public accounting firm. While management believes the procedures followed in preparing
these condensed financial statements are reasonable, the accuracy of the amounts are in some respects dependent upon the facts
that will exist, and procedures that will be accomplished by the Company later in the year. These results are not necessarily indicative
of the results to be expected for the full year.

11









These condensed unaudited financial statements
reflect all adjustments, including normal recurring adjustments, which, in the opinion of management, are necessary to present
fairly the operations and cash flows for the periods presented.



b)    Use of Estimates



The preparation of financial statements in
conformity with accounting principles generally accepted in the United States of America requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities
at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results
could differ from those estimates.



c)    Revenue Recognition



The
Company currently derives its revenues from the sales of portable solar powered products, solar rechargeable lantern/flashlight
devices, solar backpack rechargers and clothing made from recycled products.Our products are
sold directly to consumers through our own website or by direct sales. Payment is made for the products prior to delivery.



d)    Product Warranties



The
Company warrants the product from defects for 30 days from delivery to the customer.The
Company estimates its warranty costs based on historical warranty claims experience in estimating potential warranty claims. Due
to the limited sales of the Company's products, management has determined that warranty costs are immaterial and has not included
an accrual for potential warranty claims. Presently, costs related to warranty coverage are expensed as incurred. Warranty claims
are reviewed quarterly to verify that warranty liabilities properly reflect any remaining obligation based on the anticipated expenditures
over the balance of the obligation period.



e)    Research and Development Costs



Research and development costs are charged
to expense as incurred.



f)    Cash and Cash Equivalents



The Company considers all highly liquid investments
purchased with original maturities of three months or less to be cash equivalents. There were no cash equivalents at June 30, 2013
and December 31, 2012.



g) Intangible Assets



Development, registration and maintenance costs
associated with the filing and registration of patents are prepaid and amortized over the remaining life of the patent, not to
exceed 20 years.



As defined in ASC 360-10-35, “Impairment
or Disposal of Long-Lived Assets”, long-lived assets and certain identifiable intangibles to be held and used or disposed
of by an entity be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an
asset may not be recoverable.  The Company has adopted this statement and determined that no additional impairment loss
should be recognized for applicable assets at this time.





12





h)    Income Taxes



The Company accounts for income taxes in accordance
with ASC 740-10, “Income Taxes”, which requires an asset and liability approach to financial accounting and reporting
for income taxes. Deferred income taxes and liabilities are computed annually for differences between the financial statement and
the tax basis of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws
and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established
when necessary to reduce deferred tax assets to the amount expected to be realized.



i)    Derivative Liabilities



The Company accounts for its embedded conversion
features in its convertible debentures in accordance ASC 815-10, "Derivatives and Hedging", which requires a periodic
valuation of their fair value and a corresponding recognition of liabilities associated with such derivatives, and ASC 815-40,
“Contracts in Entity’s Own Equity”. The recognition of derivative liabilities related to the issuance of convertible
debt is applied first to the proceeds of such issuance as a debt discount, at the date of issuance, and the excess of derivative
liabilities over the proceeds is recognized as “Loss on Valuation of Derivative” in other expense in the accompanying
financial statements. Any subsequent increase or decrease in the fair value of the derivative liabilities is recognized as “Other
expense” or “Other income”, respectively.



j)    Fair Value of Instruments



The carrying amount reported in
the balance sheet for cash and cash equivalents, deposits, prepaid expenses, accounts payable, and accrued expenses approximate
fair value because of the immediate or short-term maturity of these financial instruments. The carrying amount reported for notes
payable approximates fair value because, in general, the interest on the underlying instruments fluctuates with market rates.





k)     Concentrations of Credit Risk



Financial instruments that
potentially subject the Company to concentrations of credit risk consist primarily of trade accounts receivable and cash. As of
June 30, 2013 and December 31, 2012, the Company believes it has no significant risk related to its concentration within its accounts
receivable.

The Company maintains cash and cash equivalent
balances at a financial institution that is insured by the Federal Deposit Insurance Corporation up to $250,000. There were no
uninsured cash balances at June 30, 2013 and December 31, 2012.



Note 5       Income
(Loss) Per Share



ASC 260, “Earnings Per Share” requires
presentation of basic earnings per share (“basic EPS”) and diluted earnings per share (“diluted EPS”).
The Company’s basic income (loss) per common share is based on net income or loss for the relevant period, divided by the
weighted average number of common shares outstanding during the period. Diluted income or loss per common share is based on net
income or loss, divided by the weighted average number of common shares outstanding during the year, including common share equivalents,
such as outstanding stock options. The computation of diluted loss per share also does not assume conversion,
exercise or contingent exercise of securities due to the beneficial conversion of related party accounts as these shares that would
have an anti-dilutive effect.

13







The computation of income
(loss) per share is as follows:



|                                                                                                                       |  | Six months
 Ended |                |  | Six months
 Ended |  
|---------------------------------------------------------------------------------------------------------------------- |  | ----------------- | -------------- |  | ----------------- | -
|                                                                                                                       |  | June 30, 2013     |                |  | June 30, 2012     |  
|Basic net income (loss) per share computation:                                                                         |  |                   |                |  |                   |  
|Net income (loss) attributable to common stockholders                                                                  |  | $                 | 2,604,327      |  |                   | $
|Weighted-average common shares outstanding (see below)                                                                 |  |                   | 2,613,517,549  |  |                   |  
|Basic net income (loss) per share attributable to common stockholders (see below)                                      |  | $                 | 0.00           |  |                   | $
|                                                                                                                       |  |                   |                |  |                   |  
|Diluted net income (loss) per share computation                                                                        |  |                   |                |  |                   |  
|Net income (loss) attributable to common stockholders                                                                  |  | $                 | 2,604,327      |  |                   | $
|Weighted-average common shares outstanding (see below)                                                                 |  |                   | 2,613,517,549  |  |                   |  
|Incremental shares attributable to the assumed conversion of Convertible debenture and
    convertible promissory note |  |                   | 7,386,482,451  |  |                   |  
|Total adjusted weighted-average shares                                                                                 |  |                   | 10,000,000,000 |  |                   |  
|Diluted net income (loss) per share attributable to common stockholders (see below)                                    |  | $                 | 0.00           |  |                   | $





At June 30, 2013, the Company had common stock
equivalents of 27,931,196,389, but when added to the common stock outstanding, they are in excess of the authorized capital, so
the maximum authorized shares of 10,000,000,000 are shown for diluted earnings per common share calculations. At June 30, 2012
the Company had common stock equivalents of 856,435,568.



Note 6       Intangible
Assets



At June 30, 2013 and December
31, 2012, intangible assets consist of the following:



|                               |  | 2013 |          |   | 2012 |  
|------------------------------ |  | ---- | -------- | - | ---- | -
|Speech-enabled auto dialer     |  | $    | 17,025   |   |      | $
|Cancer drug delivery system    |  |      | 182,600  |   |      |  
|“Green” trademark applications |  |      | 2,145    |   |      |  
|Kenergy patent portfolio       |  |      | 26,970   |   |      |  
|Smart Bell                     |  |      | 5,000    |   |      |  
|Less: accumulated amortization |  |      | (123,760 | ) |      |  
|Intangible assets, net         |  | $    | 109,980  |   |      | $



As defined in ASC 360-10-35, “Impairment
or Disposal of Long-Lived Assets”, long-lived assets and certain identifiable intangibles to be held and used or disposed
of by an entity be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an
asset may not be recoverable.  The Company has adopted this statement and determined that no additional impairment loss
should be recognized for applicable assets at this time.





14









Note 7       Income
Taxes



Deferred income taxes will be determined using
the liability method for the temporary differences between the financial reporting basis and income tax basis of the Company's
assets and liabilities. Deferred income taxes will be measured based on the tax rates expected to be in effect when the temporary
differences are included in the Company's tax return. Deferred tax assets and liabilities are recognized based on anticipated
future tax consequences attributable to differences between financial statement carrying amounts of assets and liabilities and
their respective tax bases.



At June 30, 2013 and December 31, 2012 deferred tax assets consist
of the following:



|                          |  | 2013 |            |   | 2012 |  
|------------------------- |  | ---- | ---------- | - | ---- | -
|Deferred tax assets       |  | $    | 1,056,000  |   |      | $
|Less: valuation allowance |  |      | (1,056,000 | ) |      |  
|Net deferred tax asset    |  | $    | 0          |   |      | $





At June 30, 2013 and December 31, 2012, the
Company had federal net operating loss carry forwards in the approximate amounts of $3,105,000 and $2,900,000, respectively, available
to offset future taxable income. The Company established valuation allowances equal to the full amount of the deferred tax assets
due to the uncertainty of the utilization of the operating losses in future periods.



Note 8       Related
Party Transactions



On June 1, 2009 and June 2, 2009, the Company
issued two (2) one-year promissory notes in the aggregate of $37,000 to GlynnTech, Inc, for GlynnTech to assume a like amount of
current obligations that the Company was unable to pay from current operations. The debt was due on or before the 1st
anniversary and was interest free.



On June 18, 2009, the Company acquired the
patent rights and technology relating to cancer drug delivery systems developed by GlynnTech, Inc. by the issuance of three (3)
$100,000 one-year promissory notes. The promissory notes were due on or before the 1st anniversary of the notes and
were interest free.



On December 28, 2009, the Company completed
the transfer of the patent rights and technology relating to cancer drug delivery systems developed by GlynnTech, Inc. by the issuance
of three (3) one-year promissory notes for the aggregate amount of $125,000. The promissory notes are due on or before the 1st
anniversary of the notes and are interest free.



On June 8, 2010 and June 22, 2010, the Company
executed two wrap-around agreements, in an aggregate of $337,000, to assign amounts due under these one-year promissory notes to
EPIC Worldwide, Inc. The Company was in default on the original notes and this allowed the Company to extend the payment terms
for an additional year while the Company attains alternate financing.



On July 1, 2012, the Company consented to the
assignment of one of the GlynnTech, Inc promissory notes from GlynnTech to Charles Basner in the amount of $50,000. All terms of
the original note are unchanged.





15









The aggregate value of the GlynnTech promissory
notes are $75,000 at June 30, 2013 and December 31, 2012. For the six months ended June 30, 2013, the Company calculated $2,350
as imputed interest at a rate of 6.25% which was charged to interest expenses and credited to Additional paid-in capital.



On June 17, 2009, Kenneth P. Glynn, President
and CEO of the Company, acquired debt owed by the Company to third party creditors as follows:



|(1) | Promissory Note due to Jerome Mahoney dated August 5, 2005 having a balance on June 17, 2009 of $71,756 and accrued interest of $98,379;
|--- | ----------------------------------------------------------------------------------------------------------------------------------------



|(2) | Deferred Compensation due to Jerome Mahoney as of June 17, 2009 equal to $319,910;
|--- | ----------------------------------------------------------------------------------



|(3) | Convertible promissory note to iVoice, Inc. dated March 5, 2008 having a balance on June 17, 2009, $79,936 and accrued interest of $4,344; and
|--- | ----------------------------------------------------------------------------------------------------------------------------------------------



|(4) | Loan from iVoice Technology, Inc. to SpeechSwitch, Inc. in the amount of $3,600.
|--- | --------------------------------------------------------------------------------



The outstanding promissory note, referred to
above, will bear interest at the rate of Prime plus 1.0% per annum on the unpaid balance until paid. Under the terms of the Promissory
Note, at the option of the Promissory Note holder, principal and interest can be converted into either (i) one share of SpeechSwitch
Class B Common Stock, par value $.01 per share, for each dollar owed, (ii) the number of shares of SpeechSwitch Class A Common
Stock calculated by dividing (x) the sum of the principal and interest that the Note holder has requested to have prepaid by (y)
eighty percent (80%) of the lowest issue price of Class A Common Stock since the first advance of funds under this Note, or (iii)
payment of the principal of this Promissory Note, before any repayment of interest. The Board of Directors of the Company maintains
control over the issuance of shares and may decline the request for conversion of the repayment into shares of the Company.



The amount of deferred compensation, referred
to above, was added to the outstanding promissory note for calculations of accrued interest and is payable in the form of cash,
debt, or shares of our Class B Common Stock.



On May 27, 2010, the Company issued an aggregate
of 7,057,328 (5,645,862,500 pre-reverse split) shares of Class A common stock and 10,000 shares of Class B common stock to Mr.
Glynn in settlement of $509,425 (items #1 and #2 above) of promissory notes and accrued interest due to Mr. Glynn. These shares
contain a restrictive legend which will limit Mr. Glynn from liquidating these into the open market.



During the year ended December 31, 2012, the
Company issued an aggregate of 1,202,057,500 shares of Class A common stock to Mr. Glynn as repayment of $120,823 of deferred compensation
and accrued interest that Mr. Glynn earned in 2009 and 2010. These shares contain a restrictive legend which will limit Mr. Glynn’s
ability to liquidate these into the open market.



On June 26, 2013, the Company issued a Promissory
Note to Mr. Glynn for $180,000 representing earned and unpaid deferred compensation.



On June 30, 2013, Mr. Glynn assigned the remaining
balance of his notes and deferred compensation to Mina Mar Group pursuant to the terms of the LOI between himself and Mina Mar
Group executed on May 31, 2013. The outstanding balance at June 30, 2013 was $85,329.



During the three years ended December 31, 2012,
GlynnTech, Inc and affiliates have paid some bills on behalf of the Company. As of June 30, 2013, the aggregate amounts due for
these payments is $20,738.





16







On July 1, 2012, the Company extended the
Administrative Services Agreement with GlynnTech, Inc to provide back office administrative support to the Company. The administrative
services agreement was for an initial term of one year and was extended for an additional one-year periods at the Company’s
request. The amended fees are $7,500 per month but may be reduced in scope or eliminated at any time upon 90 days’ prior
written notice by the Company to GlynnTech. Effective on June 1, 2013, certain intangible assets related to the Alternative Energy
Portfolio patents and patent applications were assigned to GlynnTech in exchange for a reduction of unpaid administrative service
fees in the aggregate value of $45,000.



Per agreement with GlynnTech, Inc, Kenergy
continued to sell the GreenSmart store products on a consignment basis to fulfill customer requirements. Per the agreement, Kenergy
retains a 10% retainer to offset administrative costs of processing the transactions. As of June 30, 2013, Kenergy owes $1,665
to GlynnTech for products sold to our customers.



Note 9       Promissory
Note (Related Party)



The Company had entered into a temporary administrative
services agreement with iVoice in 2004. The administrative services agreement continued on a month-to-month basis until December
31, 2008 at which point the agreements were suspended by mutual consent of the parties.



In March 2008, the administrative services
agreement was amended to provide that accrued and unpaid administrative services shall be segregated and converted into a Convertible
Promissory Note. The principal and interest shall be due and payable as follows: (a) interest shall accrue monthly on the unpaid
balance and shall be paid annually, and (b) principal shall be payable on demand.



On
March 5, 2008, the Company converted its outstanding accounts payable to
iVoice, Inc. for unpaid administrative services in the amount of $50,652 into a convertible promissory note at the rate of prime
plus 1 percent per annum. Additional amounts of $42,209 were added to this note based on any unpaid administrative services, and
will accrue interest at the above specified rate from date of advance until paid.



On June 17, 2009, Kenneth P. Glynn (a related
party) acquired this debt from iVoice, Inc. The Note holder may elect payment of the principal and/or interest, at the its sole
discretion, owed pursuant to this Note by requiring the Company to issue either: (i) one Class B common stock share of the Company
par value $.01 per share, for each dollar owed, (ii) the number of Class A common stock shares of the Company calculated by dividing
(x) the sum of the principal and interest that the Note holder has decided to have paid by (y) eighty percent (80%) of the lowest
issue price of Class A common stock since the first advance of funds under this Note, or (iii), payment of the principal of this
Note, before any repayment of interest.



On June 19, 2013, the Company issued an aggregate
of 2,200,000,000 shares of Class A common stock to Mr. Glynn as repayment of $88,000 of convertible debt and accrued interest.
These shares contain a restrictive legend which will limit Mr. Glynn’s ability to liquidate these into the open market.



On June 26, 2013, the Company issued a Promissory
Note to Mr. Glynn for $180,000 representing earned and unpaid deferred compensation. This note matures on July 1, 2013 and upon
default becomes convertible into Class A common stock at a conversion price of 50% of the lowest closing price of the last ten
trading days prior to notice of conversion. As of June 30, 2013, the outstanding balance on the Promissory Note was $180,000 plus
accrued interest of $0.



17







Note 10Convertible
Debenture and Derivative Liability



On March 30, 2007, the Company issued a Secured
Convertible Debenture (the "Debenture") to YA Global Investments (f/k/a/ Cornell Capital Partners) (“YA Global”)
for the sum of $1,000,000 in exchange for a previously issued notes payable for the same amount. The Debenture has a term of three
years, and pays interest at the rate of 5% per annum. YA Global has the right to convert a portion or the entire outstanding principal
into the Company's Class A Common Stock at a Conversion Price equal to eighty percent (80%) of the lowest closing Bid Price of
the Common Stock during the five (5) trading days immediately preceding the Conversion Date. YA Global may not convert the Debenture
into shares of Class A Common Stock if such conversion would result in YA Global beneficially owning in excess of 4.99% of the
then issued and outstanding shares of Class A Common Stock. The Conversion Price and number of shares of Class A Common Stock issuable
upon conversion of the Debenture are subject to certain exceptions and adjustment for stock splits and combinations and other dilutive
events. Subject to the terms and conditions of the Debenture, the Company has the right to redeem ("Optional Redemption")
a portion or all amounts outstanding under this Debenture prior to the Maturity Date at any time provided that as of the date of
the Holder's receipt of a Redemption Notice (i) the Closing Bid Price of the of the Common Stock, as reported by Bloomberg, LP,
is less than the Conversion Price and (ii) no Event of Default has occurred. The Company shall pay an amount equal to the principal
amount being redeemed plus a redemption premium ("Redemption Premium") equal to twenty percent (20%) of the principal
amount being redeemed, and accrued interest, (collectively referred to as the "Redemption Amount"). During the time that
any portion of this Debenture is outstanding, if any Event of Default has occurred, the full principal amount of this Debenture,
together with interest and other amounts owing in respect thereof, to the date of acceleration shall become at the Holder's election,
immediately due and payable in cash, provided however, the Holder may request (but shall have no obligation to request) payment
of such amounts in Common stock of the Company. Furthermore, on addition to any other remedies, the Holder shall have the right
(but not the obligation) to convert this Debenture at any time after (x) an Event of Default or (y) the Maturity Date at the Conversion
Price then in-effect. The debenture is secured by substantially all of the assets of the Company.



On July 26, 2010, the convertible debenture
with YA Global Investments, LP was amended and restated in order to replace the existing debenture with five (5) debentures of
$208,707.74 each. The term of the debentures were amended to extend the due date until July 29, 2011. The amendments had the effect
of reclassifying $156,199 of non-interest bearing accrued interest into the secured convertible debentures.



During the year ended December 31, 2010, YA
Global Investments, LP assigned the debentures that it held to E-Lionheart Associates, LLC (“E-Lionheart”) with an
aggregate value of $1,043,539. This was done in conjunction with the execution of a Securities Purchase Agreement with E-Lionheart
whereby E-Lionheart will purchase from the Company up to $500,000 of convertible debentures which will provide new financing for
the Company. The new convertible debentures are due on August 9, 2011 and have conversion rights essentially the same as YA Global.



During the year ended December 31, 2011, the
Company issued an additional 577,597 (462,077,400 pre-reverse split) shares of Class A common stock to E-Lionheart for repayment
valued at $143,244. The difference in the market value and the reduction in debt of $46,208 was charged to beneficial interest
in the amount of $97,036.



On July 29, 2011 and August 9, 2011, the Company
had defaulted on the terms of the E-Lionheart Convertible Debentures and as such, the full principal amount of these Debentures,
together with interest and other amounts owing in respect thereof, shall become at the Holder's election, immediately due and payable
in cash, provided however, the Holder may request (but shall have no obligation to request) payment of such amounts in Common stock
of the Company.

18







As of June 30, 2013, the outstanding balance
on the E-Lionheart Convertible Debentures were $626,123. During the calendar year 2011, the Company notified E-Lionheart that the
Company was disputing the balances due upon this debenture due to miscalculations of the effective conversion rates used by E-Lionheart
and as of the date of this filing, the dispute has not been settled.



In accordance with ASC 815, "Derivatives
and Hedging", the Company determined that the conversion feature of the Debenture met the criteria of an embedded derivative,
and therefore the conversion feature of this Debenture needed to be bifurcated and accounted for as a derivative. The fair value
of the embedded conversion was estimated at the date of issuance using the Black-Scholes model with the following assumptions:
risk free interest rate: 5.6%; expected dividend yield: 0%: expected life: 3 years; and volatility: 165.62%. The accounting guidance
instructs that the conversion options are a derivative liability. As such, in March 2007 the Company recorded the conversion options
as a liability, recorded a debt discount of $1,000,000, and charged Other Expense - Loss on Valuation of Derivative for $124,479,
resulting primarily from calculation of the conversion price. For the six months ended June 30, 2013, the Company recorded a Gain
on Valuation of Derivative in the amount of $1,154,814. For the year ended December 31, 2012, the Company recorded a Loss on Valuation
of Derivative in the amount of $613,148.



On June 8, 2010 and June 22, 2010, the Company
executed two wrap-around agreements, in an aggregate of $337,000, to assign amounts due under various Promissory Notes due to GlynnTech,
Inc to EPIC Worldwide, Inc. (the “Investor”). The wrap-around agreements also modified the original terms to extend
the due dates by one year, to include provisions to allow the Investor to convert the amounts due into common stock at a 50% discount
of the average three deep bid on the day of conversion and to increase the interest rate to 15% after a 60 day interest free period.



On
June 22, 2011, the Company had defaulted on the terms of the 2nd wrap-around agreements and as such, the default interest rate
was increased retroactively to 24.99% on the remaining balance of the debt. I am not sure if the Epic Agreement was cancelled
or assigned.



On March 6, 2012, the Company consented to
the cancelation of the wrap around agreement with EPIC Worldwide and the reassignment of a new wrap around agreement with ATG,
Inc. for $50,000 plus accrued interest of $26,050. Concurrent with the cancelation of the wrap around agreement, the Company also
recorded a Gain on Valuation of Derivative in the amount of $154,201 on the retirement of the derivative liability.



As of December 31, 2012, the outstanding balance
on the EPIC Convertible Notes were $0.



On August 9, 2010, the Company entered into
a securities purchase agreement with E-Lionheart to purchase up to $500,000 of convertible debentures from the Company. Amounts
due under this debenture are due on or before August 9, 2011 and pays interest at the rate of 5% per annum. E-Lionheart has the
right to convert a portion or the entire outstanding principal into the Company's Class A Common Stock at a Conversion Price equal
to eighty percent (90%) of the lowest closing Bid Price of the Common Stock during the five (5) trading days immediately preceding
the Conversion Date. E-Lionheart may not convert the Debenture into shares of Class A Common Stock if such conversion would result
in YA Global beneficially owning in excess of 4.99% of the then issued and outstanding shares of Class A Common Stock.





19







On August 9, 2011, the Company had defaulted
on the terms of this Debenture and as such, the full principal amount of this Debentures, together with interest and other amounts
owing in respect thereof, shall become at the Holder's election, immediately due and payable in cash, provided however, the Holder
may request (but shall have no obligation to request) payment of such amounts in Common stock of the Company.



In accordance with ASC 815, "Derivatives
and Hedging", the Company determined that the conversion feature of the Debenture met the criteria of an embedded derivative,
and therefore the conversion feature of this Debenture needed to be bifurcated and accounted for as a derivative. The fair value
of the embedded conversion was estimated at the date of issuance using the Black-Scholes model with the following assumptions:
risk free interest rate: 2.25%; expected dividend yield: 0%: expected life: 1 years; and volatility: 301.66% to 308.06%. The accounting
guidance instructs that the conversion options are a derivative liability. As such, on the issue dates, the Company recorded the
conversion options as a liability and recorded a debt discount of $143,408. For the six months ended June 30, 2013, the Company
recorded a Gain on Valuation of Derivative in the amount of $816,899 on the fluctuation in the current market prices. For the year
ended December 31, 2012, the Company recorded a Loss on Valuation of Derivative in the amount of $450,598 on the fluctuation in
the current market prices.



On August 26, 2011 and November 22, 2011, the
Company issued two convertible promissory notes, in an aggregate of $65,000, to Asher Enterprises, Inc. (“Asher”).
Amounts due under these notes are due on or before May 30, 2012 and August 28, 2012, respectively, and pays interest at the rate
of 8% per annum. Asher has the right to convert a portion or the entire outstanding principal into the Company's Class A Common
Stock at a Conversion Price equal to fifty five percent (55%) of the Average of the lowest three (3) Trading Prices of the Common
Stock during the ten (10) Trading Day period immediately preceding the Conversion Date. Asher may not convert the note into shares
of Class A Common Stock if such conversion would result in Asher beneficially owning in excess of 4.99% of the then issued and
outstanding shares of Class A Common Stock.



On March 13, 2012, the Company amended the
terms of the August 26, 2011 note to change the Variable Conversion Price to equal thirty five (35%) multiplied by the average
of the lowest two Trading Prices of the Common Stock during the thirty (30) Trading Day period immediately preceding the Conversion
Date.



During the year ended December 31, 2012 the
Company issued an aggregate of 63,885,238 shares of Class A common stock to Asher for repayment of debt valued at $105,230. The
difference in the market value and the reduction in debt of $25,600 was charged to beneficial interest in the amount of $79,630.
During the six months ended June 30, 2013 the Company issued an additional 363,852,814 shares of Class A common stock to Asher
for repayment of debt valued at $113,498. The difference in the market value and the reduction in debt and accrued interest of
$30,200 was charged to beneficial interest in the amount of $83,298.



As of June 30, 2013 and December 31, 2011,
the outstanding balance on these Convertible Promissory Notes was $10,700 and $39,400, respectively.



In accordance with ASC 815, "Derivatives
and Hedging", the Company determined that the conversion feature of the Debenture met the criteria of an embedded derivative,
and therefore the conversion feature of this Debenture needed to be bifurcated and accounted for as a derivative. The fair value
of the embedded conversion was estimated at the date of issuance using the Black-Scholes model with the following assumptions:
risk free interest rate: 2.25%; expected dividend yield: 0%: expected life: .75 years; and volatility: 212.29%. The accounting
guidance instructs that the conversion options are a derivative liability. As such, on the issue dates, the Company recorded the
conversion options as a liability, recorded a debt discount of $65,000, and charged Other Expense - Loss on Valuation of Derivative
for $24,294. For the six months ended June 30, 2013, the Company recorded a Gain on Valuation of Derivative in the amount of $129,917
on the fluctuation in the current market prices. For the year ended December 31, 2012, the Company recorded a Gain on Valuation
of Derivative in the amount of $83,610 on the fluctuation in the current market prices.

20







On February 16, 2012, March 14, 2012 and November
27, 2012, the Company issued an additional three (3) convertible promissory notes, in an aggregate of $60,000, to Asher Enterprises,
Inc. (“Asher”). Amounts due under these notes are due on or before November 21, 2012, December 19, 2012 and March 1,
2014, respectively, and pays interest at the rate of 8% per annum. Asher has the right to convert a portion or the entire outstanding
principal into the Company's Class A Common Stock at a Conversion Price equal to fifty five percent (55%) of the Average of the
lowest two (2) Trading Prices of the Common Stock during the twenty (20) Trading Day period immediately preceding the Conversion
Date. Asher may not convert the note into shares of Class A Common Stock if such conversion would result in Asher beneficially
owning in excess of 4.99% of the then issued and outstanding shares of Class A Common Stock.



As of June 30, 2013, the outstanding balance
on these Convertible Promissory Notes were $60,000.



In accordance with ASC 815, "Derivatives
and Hedging", the Company determined that the conversion feature of the Debenture met the criteria of an embedded derivative,
and therefore the conversion feature of this Debenture needed to be bifurcated and accounted for as a derivative. The fair value
of the embedded conversion was estimated at the date of issuance using the Black-Scholes model with the following assumptions:
risk free interest rate: 2.25%; expected dividend yield: 0%: expected life: .75 and 1.19 years; and volatility: 278.05%, 301.94%
and 473.96%, respectively. The accounting guidance instructs that the conversion options are a derivative liability. As such, on
the issue dates, the Company recorded the conversion options as a liability, recorded a debt discount of $60,000, and charged Other
Expense - Loss on Valuation of Derivative for $115,115. For the six months ended June 30, 2013, the Company recorded a Gain on
Valuation of Derivative in the amount of $147,208 on the fluctuation in the current market prices. For the year ended December
31, 2012, the Company recorded a Loss on Valuation of Derivative in the amount of $214,003 on the fluctuation in the current market
prices.



On March 6, 2012, the Company consented to
the reassignment of the outstanding balance of the EPIC Worldwide wrap around agreements to ATG, Inc. (“ATG”). The
outstanding balance of principal and accrued interest was $76,050. ATG subsequently entered into an Assignment and Assumption Agreement
with UAIM Corporation (“UAIM”) to assign $10,000 of these funds from ATG to UAIM. Amounts due under these agreements
are due on or before March 6, 2013 and pays interest at the rate of 15% per annum. ATG and UAIM have the right to convert a portion
or the entire outstanding principal into the Company's Class A Common Stock at a Conversion Price equal to $0.0005 per share. ATG
and UAIM may not convert these agreements into shares of Class A Common Stock if such conversion would result in ATG or UAIM beneficially
owning in excess of 4.99% of the then issued and outstanding shares of Class A Common Stock.



During the year ended December 31, 2012, the
Company issued an aggregate of 11,200,000 shares of Class A common stock for repayment of $5,600 of convertible debenture in lieu
of cash pursuant to the terms of the wrap around agreement.



As of June 30, 2013, the outstanding balance
on these agreements were $70,450.



In accordance with ASC 815, "Derivatives
and Hedging", the Company determined that the conversion feature of the Debenture met the criteria of an embedded derivative,
and therefore the conversion feature of this Debenture needed to be bifurcated and accounted for as a derivative. The fair value
of the embedded conversion was estimated at the date of issuance using the Black-Scholes model with the following assumptions:
risk free interest rate: 2.25%; expected dividend yield: 0%: expected life: 1.00 years; and volatility: 295.14. The accounting
guidance instructs that the conversion options are a derivative liability. As such, on the issue dates, the Company recorded the
conversion options as a liability, recorded a debt discount of $76,050, and charged Other Expense - Loss on Valuation of Derivative
for $2,925,649. For the six months ended June 30, 2013, the Company recorded a Gain on Valuation of Derivative in the amount of
$43,396 on the fluctuation in the current market prices. For the year ended December 31, 2012, the Company recorded a Gain on Valuation
of Derivative in the amount of $2,954,881 on the fluctuation in the current market prices.

21







In conjunction with the consent and assignment
of $45,000 of the Basner note (see Note 11) to Southridge Partners II LP (“Southridge Allonges”), the Company consented
to provide Southridge with the right to convert a portion or the entire outstanding principal into the Company's Class A Common
Stock at a Conversion Price equal to sixty percent (60%) of the lowest closing bid price of the Common Stock during the five (5)
trading days immediately preceding the Conversion Date. Southridge may not convert the note into shares of Class A Common Stock
if such conversion would result in Southridge beneficially owning in excess of 9.99% of the then issued and outstanding shares
of Class A Common Stock.



On January 30, 3013 and March 11, 2013, the
Company issued two convertible promissory notes, in an aggregate of $10,000, to Southridge Partners II LP (“Southridge Debt”).
Amounts due under these notes are due on or before January 31, 2014 and March 31, 2014, respectively. Southridge has the right
to convert a portion or the entire outstanding principal into the Company's Class A Common Stock at a Conversion Price equal to
the lesser of (a) $0.01 or (b) fifty percent (50%) of the lowest closing bid price during the twenty (20) trading days immediately
preceding the Conversion Date.



During the year ended December 31, 2012, the
Company issued an aggregate of 58,102,182 shares of Class A common stock for repayment of $45,000 of convertible debt to Southridge
in lieu of cash pursuant to the terms of the Securities Transfer Agreement.



As of June 30, 2013, the outstanding balance
on the Southridge Debt was $10,000.



In accordance with ASC 815, "Derivatives
and Hedging", the Company determined that the conversion feature of the Southridge Allonge met the criteria of an embedded
derivative, and therefore the conversion feature of this debenture needed to be bifurcated and accounted for as a derivative. The
fair value of the embedded conversion was estimated at the date of issuance using the Black-Scholes model with the following assumptions:
risk free interest rate: 2.25%; expected dividend yield: 0%: expected life: .25 years; and volatility: 368.97%. The accounting
guidance instructs that the conversion options are a derivative liability. As such, on the issue dates, the Company recorded the
conversion options as a liability in the aggregate of $75,519, recorded a debt discount in the aggregate of $45,000, and charged
Other Expense - Loss on Valuation of Derivative in the aggregate for $30,519. For the six months ended June 30, 2013, the Company
recorded a Loss on Valuation of Derivative in the amount of $5,535 on the fluctuation in the current market prices. For the year
ended December 31, 2012, the Company recorded a Gain on Valuation of Derivative in the amount of $42,589 on the fluctuation in
the current market prices.



In conjunction with the consent and assignment
of $93,700 of the Basner notes, DeJonge notes and Opal notes (see Note 11) to Star City Capital, LLC (“Star City Allonges”),
the Company consented to provide Star City with the right to convert a portion or the entire outstanding principal into the Company's
Class A Common Stock at a Conversion Price equal to fifty percent (50%) of the lowest closing bid price of the Common Stock during
the five (5) trading days immediately preceding the Conversion Date. Star City may not convert the note into shares of Class A
Common Stock if such conversion would result in Star City beneficially owning in excess of 9.99% of the then issued and outstanding
shares of Class A Common Stock.





22







During the year ended December 31, 2012, the
Company issued an aggregate of 132,365,250 shares of Class A common stock for repayment of $24,969 of convertible debt and interest
to Star City in lieu of cash pursuant to the terms of the various Securities Transfer Agreements.



During the six months ended June 30, 2013,
the Company issued an aggregate of 918,100,200 shares of Class A common stock for repayment of $48,553 of convertible debt and
interest to Star City in lieu of cash pursuant to the terms of the various Securities Transfer Agreements.



As of June 30, 2013, the outstanding balance
on the Star City Allonges was $17,170.



In accordance with ASC 815, "Derivatives
and Hedging", the Company determined that the conversion feature of the Star City Allonge met the criteria of an embedded
derivative, and therefore the conversion feature of this debenture needed to be bifurcated and accounted for as a derivative. The
fair value of the embedded conversion was estimated at the date of issuance using the Black-Scholes model with the following assumptions:
risk free interest rate: 2.25%; expected dividend yield: 0%: expected life: .25 years; and volatility: 373.96%. The accounting
guidance instructs that the conversion options are a derivative liability. As such, on the issue date, the Company recorded the
conversion options as a liability of an aggregate of $38,090, recorded a debt discount of an aggregate of $25,000, and charged
Other Expense - Loss on Valuation of Derivative for an aggregate of $13,090. . For the six months ended June 30, 2013, the Company
recorded a Gain on Valuation of Derivative in the amount of $65,513 on the fluctuation in the current market prices. For the year
ended December 31, 2012, the Company recorded a Loss on Valuation of Derivative in the amount of $24,595 on the fluctuation in
the current market prices.



In conjunction with the consent and assignment
of $8,400 of the DeJonge notes (see Note 11) to Vera Group, LLC (“Vera Group”), the Company consented to provide Vera
Group with the right to convert a portion or the entire outstanding principal into the Company's Class A Common Stock at a Conversion
Price equal to fifty percent (50%) of the lowest closing bid price of the Common Stock during the twenty (20) trading days immediately
preceding the Conversion Date. Vera Group may not convert the note into shares of Class A Common Stock if such conversion would
result in Vera Group beneficially owning in excess of 9.99% of the then issued and outstanding shares of Class A Common Stock.



On March 31, 2013, the Company issued a 10%
Convertible Promissory Note to Vera Group. Amounts due under this note is due on or before March 31, 2014. Vera Group with the
right to convert a portion or the entire outstanding principal into the Company's Class A Common Stock at a Conversion Price equal
to fifty percent (50%) of the lowest closing bid price of the Common Stock during the twenty (20) trading days immediately preceding
the Conversion Date. Vera Group may not convert the note into shares of Class A Common Stock if such conversion would result in
Vera Group beneficially owning in excess of 9.99% of the then issued and outstanding shares of Class A Common Stock.



During the six months ended June 30, 2013,
the Company issued an aggregate of 169,190,000 shares of Class A common stock for repayment of $8,460 of convertible debt and interest
to Vera Group in lieu of cash pursuant to the terms of the various Securities Transfer Agreements.



As of June 30, 2013, the outstanding balance
on the Vera Group was $5,000.



23







In accordance with ASC 815, "Derivatives
and Hedging", the Company determined that the conversion feature of the Southridge Allonge met the criteria of an embedded
derivative, and therefore the conversion feature of this debenture needed to be bifurcated and accounted for as a derivative. The
fair value of the embedded conversion was estimated at the date of issuance using the Black-Scholes model with the following assumptions:
risk free interest rate: 2.25%; expected dividend yield: 0%: expected life: 1.13 years; and volatility: 464.43%. The accounting
guidance instructs that the conversion options are a derivative liability. As such, on the issue date, the Company recorded the
conversion options as a liability of an aggregate of $19,868, recorded a debt discount of an aggregate of $5,000, and charged Other
Expense - Loss on Valuation of Derivative for an aggregate of $14,868. For the six months ended June 30, 2013, the Company recorded
a Gain on Valuation of Derivative in the amount of $10,484 on the fluctuation in the current market prices.



Note 11       Promissory
Notes



On June 15, 2011, the Company issued a promissory
note, in an aggregate of $25,000, to Stuart W. DeJonge (“DeJonge”). Amounts due under this note are due on or before
January 15, 2012 and pays interest at the rate of 9% per annum. On January 15, 2012, the Company defaulted on this note and as
such, the lender may take whatever action he may elect to recover his loss while continuing to accrue 9% interest. In February
2013, the Company consented to the assignment an aggregate of $28,770 of the DeJonge note and accrued interest to affiliates of
Star City Capital, LLC and Vera Group, LLC. On February 27, 2013, the Company issued replacement promissory notes, in the aggregate
of $20,000. On May 7, 2013, the Company issued a replacement promissory note that provides conversion rights in the event of default
after February 28, 2014. As of June 30, 2013, the outstanding balance on the new DeJonge notes was $20,000 and accrued interest
of $608.



On July 12, 2011, the Company issued a promissory
note, in an aggregate of $15,000, to Opal Marketing Corp. (“Opal”). Amounts due under this note are due on or before
March 15, 2012 and pays interest at the rate of 7% per annum. On March 15, 2012, the Company defaulted on this note and as such,
the lender may take whatever action he may elect to recover his loss while continuing to accrue 7% interest. On February 19, 2013,
the Company consented to the assignment of $15,000 of the Opal note to affiliates of Star City Capital, LLC. As of June 30, 2013,
the outstanding balance on the Opal Marketing Corp. note was $0 and accrued interest of $1,671.



On July 22, 2011, the Company issued a promissory
note, in an aggregate of $100,000, to Charles M. Basner (“Basner”). Amounts due under this note are due on or before
March 22, 2012 and pays interest at the rate of 7% per annum. On March 22, 2012, the Company defaulted on this note and as such,
the lender may take whatever action he may elect to recover his loss while continuing to accrue 7% interest. During the year ended
December 31, 2012 and the six months ended June 30, 2013, the Company consented to the assignment an aggregate of $100,000 of the
Basner note to Southridge Partners II LP and to Star City Capital, LLC. During the year ended December 31, 2012 and the six months
ended June 30, 2013, the Company issued replacement promissory notes, in the aggregate of $91,600. On May 7, 2013, the Company
issued a replacement promissory note that provides conversion rights in the event of default after February 4, 2014. On July 1,
2012, the Company consented to the assignment of one of the GlynnTech, Inc promissory notes from GlynnTech to Charles Basner in
the amount of $50,000. All terms of the original note are unchanged. On May 7, 2013, the Company issued a replacement promissory
note that provides conversion rights in the event of default after July 1, 2013. As of June 30, 2013, the aggregate balances balance
on the Basner notes was $141,600 and accrued interest of $14,260.



On July 22, 2012, the Company issued a promissory
note, in an aggregate of $25,000, to Fred Erxleben. Amounts due under this note are due on or before January 25, 2013 and pays
interest at the rate of 10% per annum. On January 25, 2013, the Company defaulted on this note and as such, the lender may take
whatever action he may elect to recover his loss while continuing to accrue 10% interest. As of June 30, 2013, the outstanding
balance on the Fred Erxleben note was $25,000 and accrued interest of $2,349.





24









Note 12       Capital
Stock



Pursuant to Kenergy Scientific's certificate
of incorporation, as amended, as of June 30, 2013, the Company is authorized to issue 1,000,000 shares of Preferred Stock, par
value of $1.00 per share, 10,000,000,000 shares of Class A Common Stock, no par value per share, 50,000,000 shares of Class B
Common Stock, par value $0.01 per share, and 20,000,000 shares of Class C Common Stock, par value $0.01 per share. Below is a
description of Kenergy Scientific's outstanding securities, including Preferred Stock, Class A Common Stock, Class B Common Stock,
and Class C Common Stock.



On March 5, 2012, the Company amended its Certificate
of Incorporation to increase the number of authorized Class A Common Stock Shares to 625,000,000, as authorized by the Board of
Directors and adopted by the shareholders on February 15, 2012. The effect of this amendment was to increase the authorized shares
from 125,000,000 to 625,000,000.



On November 28, 2012, the Company amended its
Certificate of Incorporation to increase the number of authorized Class A Common Stock Shares to 4,000,000,000, as authorized by
the Board of Directors and adopted by the shareholders on November 15, 2012. The effect of this amendment was to increase the authorized
shares from 625,000,000 to 4,000,000,000.



On June 11, 2013, the Company amended its Certificate
of Incorporation to increase the number of authorized Class A Common Stock Shares to 10,000,000,000, as authorized by the Board
of Directors and adopted by the shareholders on April 1, 2013. The effect of this amendment was to increase the authorized shares
from 4,000,000,000 to 10,000,000,000.



a) Preferred Stock



As of June 30, 2013, Kenergy Scientific has
issued 75,000 shares of Preferred Stock to Southridge Partners II LP (the “Investor”), pursuant to the terms of the
Equity Purchase Agreement. These shares shall be convertible at the option of the Investor into shares of the Company’s common
stock at a conversion price equal to seventy percent (70%) of the average of the two (2) lowest Closing Prices for the five (5)
trading days immediately preceding a conversion notice. The Preferred Stock shall have no registration rights.



For
the year ended December 31, 2012, the Company had the following transactions in itsPreferred stock:



|i) | The Company issued 75,000 shares of Preferred Stock, $1.00 par value, to Southridge Partners II LP, pursuant to the terms of the Equity Purchase Agreement finalized on July 16, 2012
|-- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



For
the six months ended June 30, 2013, the Company had the following transactions in itsPreferred stock:



|i) | The Company issued an aggregate of 86,304,147 shares of Class A common stock in exchange for an aggregate of 12,370 shares of Preferred Stock, $1.00 par value, to Southridge Partners II LP, pursuant to the terms of the Equity Purchase Agreement finalized on July 16, 2012
|-- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------





25









b) Class A Common Stock



As of June 30, 2013 and December
31, 2012, there are 10,000,000,000 and 4,000,000,000 shares, respectively, of Class A Common Stock authorized, no par value, and
5,217,475,719 and 1,480,028,558 shares, respectively, were issued and outstanding.



Each holder of Class A Common Stock is entitled
to receive ratably dividends, if any, as may be declared by the Board of Directors out of funds legally available for payment of
dividends. The Company has never paid any dividends on its common stock and does not contemplate doing so in the foreseeable future.
The Company anticipates that any earnings generated from operations will be used to finance its growth objectives.



For the six months ended
June 30, 2013, the Company had the following transactions in its Class A common stock:



|(a) | The Company issued an aggregate of 363,852,814 shares of Class A common stock for repayment of convertible debenture and accrued interest in lieu of cash, valued at $113,498. The difference in the market value and the reduction in debt of $30,200 was charged to beneficial interest in the amount of $83,298.     
|--- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|(b) | The Company issued an aggregate of 918,100,200 shares of Class A common stock for repayment of convertible debenture and accrued interest in lieu of cash, valued at $173,198. The difference in the market value and the reduction in debt of $48,553 was charged to beneficial interest in the amount of $124,645.    
|(c) | The Company issued an aggregate of 169,190,000 shares of Class A common stock for repayment of convertible debenture and accrued interest in lieu of cash, valued at $23,735. The difference in the market value and the reduction in debt of $8,460 was charged to beneficial interest in the amount of $15,275.       
|(d) | The Company has issued an aggregate of 86,304,147 shares of Class A common stock upon conversion of an aggregate of 12,730 shares of Convertible Preferred Shares with Southridge Partners pursuant to the terms of the Equity Purchase Agreement finalized on July 16, 2012.                                           
|(e) | The Company issued 2,200,000,000 shares of Class A common stock to Mr. Glynn as repayment of $88,000 of deferred compensation and accrued interest that Mr. Glynn earned in 2009, 2010 and 2011. These shares contain a restrictive legend which will limit Mr. Glynn’s ability to liquidate these into the open market.



c) Class B Common Stock



As of June 30, 2013, there are 50,000,000 shares
of Class B Common Stock authorized, par value $.01 per shareand 10,000 shares were issued and outstanding.
Each holder of Class B Common Stock has voting rights equal to 100 shares of Class A Common Stock. A holder of Class B Common Stock
has the right to convert each share of Class B Common Stock into the number of shares of Class A Common Stock determined by dividing
the number of Class B Common Stock being converted by a 20% discount of the lowest price that Kenergy Scientific, Inc. had ever
issued its Class A Common Stock. Upon liquidation, dissolution, or winding-up, holders of Class B Common Stock will be entitled
to receive distributions.



d) Class C Common Stock



As of June 30, 2013, there are 20,000,000 shares
of Class C Common Stock authorized, par value $.01 per share. Each holder of Class C Common Stock is entitled to 1,000 votes for
each share held of record. Shares of Class C Common Stock are not convertible into Class A Common Stock. Upon liquidation, dissolution
or wind-up, the holders of Class C Common Stock are not entitled to receive the Company’s net assets pro rata. As of June
30, 2013, no shares were issued or outstanding.





26







Note 13       Additional
paid-in capital



As of June 30, 2013, the Company has owed
as much as $437,000 to a related party director of the Company. The loans are non-interest bearing, unsecured and due at various
times up to December 28, 2010 and are included in the loans payable, related party balance. However, ASC 835-30 “Imputation
of Interest” has been applied to impute the interest on loan from June 1, 2009 as there was no interest rate stipulated
in the agreements. An accumulation of $45,620 has been imputed as interest over the periods and as per ASC 835-30, has been credited
to Additional paid-in capital.



Note 14Stock Options



During 2005, the Company adopted the 2005 Stock
Incentive Plan and the 2005 Directors’ and Officers’ Stock Incentive Plan (“Plan”) in order to attract
and retain qualified personnel. Under the Plans, the Board of Directors, in its discretion may grant stock options (either incentive
or non-qualified stock options) to officers, directors and employees. The Company has not issued any stock options as of June 30,
2013.



Note 15New Accounting Pronouncements



There were various other updates recently issued,
most of which represented technical corrections to the accounting literature or application to specific industries and are not
expected to a have a material impact on the Company's financial position, results of operations or cash flows.



Note 16        
Fair Value Measurements



ASC 825-10 defines fair value as the price
that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants
at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded
at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions
that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk
of nonperformance. ASC 825-10 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs
and minimize the use of unobservable inputs when measuring fair value. ASC 825-10 establishes three levels of inputs that may be
used to measure fair value:



Level 1 - Quoted prices in active markets for
identical assets or liabilities.



Level 2 - Observable inputs other than Level
1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent
transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived
principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.



Level 3 - Unobservable inputs to the valuation
methodology that are significant to the measurement of fair value of assets or liabilities.



To the extent that valuation is based on models
or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain
cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure
purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed is determined based on the
lowest level input that is significant to the fair value measurement.



27







Items recorded or measured at fair value on
a recurring basis in the accompanying financial statements consisted of the following items as of June 30, 2013 and December 31,
2012.



June 30, 2013



|                             |  | Level I |   |  | Level II |   |   | Level III |  |   | Total     | 
|---------------------------- |  | ------- | - |  | -------- | - | - | --------- |  | - | --------- | 
|Convertible promissory notes |  | $       | – |  |          | $ | – |           |  | $ | 1,279,598 | 
|Total Liabilities            |  | $       | – |  |          | $ | – |           |  | $ | 1,279,598 | 



December 31, 2012



|                             |  | Level I |   |  | Level II |   |   | Level III |  |   | Total     | 
|---------------------------- |  | ------- | - |  | -------- | - | - | --------- |  | - | --------- | 
|Convertible promissory notes |  | $       | – |  |          | $ | – |           |  | $ | 1,269,018 | 
|Total Liabilities            |  | $       | – |  |          | $ | – |           |  | $ | 1,269,018 | 



Note 19        
Subsequent Events



On July 2 2013, the Company announced that it secured certain complex
financing via the sale of preferred shares. The new majority preferred shareholder, and stakeholder Mina Mar Group Inc, a Canadian
based M&A and IR firm has provided significant support in terms of both personnel and resources.



The Company also announced that:



| | · | Effective June 30, 2013 Ken Glynn has resigned from his positions
at Kenergy Scientific, Inc. (KNSC), including President and Chairman of the Board,
| | - | ----------------------------------------------------------------------------------------------------------------------------------------------------

| | · | Ken Moser has simultaneously resigned from the Board of Directors.
| | - | ------------------------------------------------------------------

| | · | KNSC had already divested itself of the GreenSmart Store, sold off
inventory at a price slightly above costs, and had divested itself of the alternative energy and biobandage patents and applications,
also for a price above costs.
| | - | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------





On July 4, 2013, the Company accepted the resignation of Teresa
Rubio as Secretary and Treasurer.





On July 26, 2013, the Company terminated merger
discussions with PanTuffa Group and accepted the resignation of Charles Zein as President to Kenergy.



On August 8, 2013 the Company secured a $1
million dollar revolving line of credit at 5% per annual interest rate with its preferred shareholder Mina Mar Group. The funds
are used to fund daily operations develop the Sparx Media business and settle creditor debts.



On August 14 2013 the Company launched operations
of its Sparx Business Media company.





On September 13, 2013, the Company terminated
the employment contract with Manuel Canales and accepted the resignation of Andrea Zecevic and Hugo Rubio as Board Members. In
addition Zoran Cvetojevic was appointed Interim CEO.





28









|Item 2. | MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|------- | -------------------------------------------------------------------------------------



Forward Looking Statements



A number of the statements made by the Company
in this report may be regarded as “forward-looking statements” within the meaning of the Private Securities Litigation
Reform Act of 1995.



Forward-looking statements include, among others,
statements concerning the Company’s outlook, pricing trends and forces within the industry, the completion dates of capital
projects, expected sales growth, cost reduction strategies and their results, long-term goals of the Company and other statements
of expectations, beliefs, future plans and strategies, anticipated events or trends and similar expressions concerning matters
that are not historical facts.



All predictions as to future results contain
a measure of uncertainty and accordingly, actual results could differ materially. Among the factors that could cause a difference
are: changes in the general economy; changes in demand for the Company’s products or in the cost and availability of its
raw materials; the actions of its competitors; the success of our customers; technological change; changes in employee relations;
government regulations; litigation, including its inherent uncertainty; difficulties in plant operations and materials; transportation,
environmental matters; and other unforeseen circumstances. For a discussion of material risks and uncertainties that the Company
faces, see the discussion in the Form 10−K for the fiscal year ended December 31, 2012 entitled “Risk Factors”.



Overview and Plan of Operation

In June 2009, the Company entered into fields
of development of various products relating to solar power generating systems; portable solar powered products, such as cell phone
and PDA rechargers that are solar rechargeable; solar rechargeable lantern/flashlight devices; solar backpack rechargers; solar
power audio devices, such as radios; wind power generating systems; and, creative products based on proprietary positions, especially
in the area of healthcare. On February 4, 2013, the Company announced that they would be closing their GreenSmart store and “would
seek a new business entity acquisition to change its direction and its financial status”. Following the change of management
on July 1, 2013 the Company commenced development of a wholly owned media company under the brand name Sparx Business Media. The
Company will earn licensing revenue from Sparx.



Results of Operations



During the
six months ended June 30, 2013, the Company sold $8,052 of solar powered products and products made from recycled materials as
compared to $24,191 for the six months ended June 30, 2012. During the three months ended June 30, 2013, the Company sold $2,363
of solar powered products and products made from recycled materials as compared to $7,669 for the three months ended June 30, 2012.
This decrease is primarily due to the decline in interest in Green products at the company-owned retail GreenSmart store which
closed the store front in the 1st quarter of 2013.



Gross margin for the six
and three months ended June 30, 2013 of $470 and $236, respectively, represents a Gross margin % to sales of 5.8% and 10%, respectively.
For the six and three months ended June 30, 2012, Gross margin % to sales of 48.2% and 48.0%, respectively. These decrease in margin
% is the result of giving heavy discounts to loyal customers as the Company moved to close the company-owned retail GreenSmart
store.

29









Total operating expenses
decreased $57,190 (19.5%) to $235,459 for the six months ended June 30, 2013, as compared to the same period in the prior year.
Total operating expenses decreased $44,714 (34.8%) to $83,746 for the three months June 30, 2013, as compared to the same period
in the prior year. The decreases were primarily the result of lower professional fees and lower overhead costs of the GreenSmarft
store offset by increases in general operating expenses and higher deferred salaries.



Total other income (expense)
for the threesix months ended June 30, 2013 was total income of $2,839,316 as compared to total expense of $9,575,866 for the six
months ended June 30, 2012, for a favorable change of $12,415,182. This change was primarily attributed to the change from a loss
to a gain on revaluation of derivatives of $6,508,576, lower beneficial interest expense of $5,874,917 and a decrease in amortization
of debt discount of $29,147 when compared to the prior year. Total other income (expense) for the three months ended June 30, 2013
was total income of $1,805,541 as compared to total expense of $7,896,743 for the three months ended June 30, 2012, for a favorable
change of $9,702,284. This change was primarily attributed to a lower beneficial interest expense of $6,069,546, a favorable change
from a loss to a gain on revaluation of derivatives of $3,580,294 and a decrease in amortization of debt discount of $45,215 when
compared to the prior year.



Net income for the six and
three months ended June 30, 2013 was $2,604,327 and $1,722,031, respectively, as compared to a net loss of $9,856,862 and $8,021,524,
respectively, for the six and three months ended March 30, 2012. The favorable changes for the six and three months ending June
30, 2013 were primarily from the favorable changes in revaluation of derivatives, lower beneficial interest, lower amortization
of debt discount and lower operating expense offset by lower gross margin.



Liquidity and Capital Resources



To date, Kenergy Scientific
has incurred substantial cash losses, and will require financing for working capital to meet its operating obligations. We anticipate
that we will require financing on an ongoing basis for the foreseeable future.



During the six months ended June 30, 2013,
the Company was able to raise an additional $50,000 of additional short term trade debt from unrelated investors.



The Company will need additional funds to implement
our business plan as our business model requires significant capital expenditures. We will need substantially more capital to execute
our business plan. Our future capital requirements will depend on a number of factors, including our ability to grow our revenues
and manage our business. Our growth will depend upon our ability to raise additional capital, possibly through the issuance of
long-term or short-term indebtedness or the issuance of our equity securities in private or public transactions. If we are successful
in raising equity capital, because of the number and variability of factors that will determine our use of the capital, our ultimate
use of the proceeds may vary substantially from our current plans. We expect that our management will have considerable discretion
over the use of equity proceeds.



For the six months ended months June 30, 2013,
the Company had a net decrease in cash of $807. The Company’s principal sources and uses of funds were as follows:



Cash used by operating activities.The Company used $50,807 in cash for operating activities for the six months ended June 30, 2013 and used $40,957 in cash for
operating activities for the six months ended June 30, 2012. The current cash operating losses of $274,331 are being partially
funded by deferred payments to vendors and related parties.

30









Cash used by investing activities.The Company used $2,470 in cash for investing activities for the six months ended June 30, 2012. These amounts were for the
prosecution and filings related to the Company’s patent portfolio.



Cash provided by financing activities.
For the six months ended June 30, 2013, the Company provided $50,000 in financing activities by the issuance of promissory notes
to unrelated parties.



There was no significant impact on the Company’s
operations as a result of inflation for the six months ended June 30, 2013.



Financing Commitments



On July 16, 2012, the Company finalized an
equity facility with Southridge Partners II, LP, a Delaware limited partnership (“Southridge”), whereby the parties
entered into (i) an equity purchase agreement and (ii) a registration rights agreement. Pursuant to the terms of the Equity Agreement,
for a period of twenty-four (24) months commencing on the effective date of the initial Registration Statement covering the Registrable
Securities, Southridge shall commit to purchase up to $17,500,000 of the Company’s Class A common stock, no par value per
share (the “Put Shares”). The purchase price of the Put Shares under the Equity Agreement is equal to ninety-one percent
(91%) of the lowest closing price of the stock following the five (5) trading days after which a put notice is deemed delivered
to Southridge in the manner provided by the Equity Agreement. The Company also entered into the Registration Rights Agreement with
Southridge. Pursuant to the terms of the Registration Rights Agreement, the Company is obligated to file a registration statement
with the U.S. Securities and Exchange Commission to cover the Registrable Securities within 90 days of closing and thereafter the
Company shall use its commercially reasonable efforts to cause the Registration Statement to be declared effective by the SEC within
five (5) business days after notice from the SEC that the Registration Statement may be declared effective.



On August 8, 2013 the Company secured a $1
million dollar revolving line of credit at 5% per annual interest rate with its preferred shareholder Mina Mar Group. The funds
are used to fund daily operations develop the Sparx Media business and settle creditor debts.



Critical Accounting Policies



The discussion and analysis
of our financial condition and results of operations are based on our financial statements, which have been prepared in accordance
with accounting principles generally accepted in the United States of America (GAAP). The preparation of these financial statements
requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and
related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate these estimates, including those related
to bad debts, inventory obsolescence, intangible assets, payroll tax obligations, and litigation. We base our estimates on historical
experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form
the basis for making judgments about the carrying values of certain assets and liabilities. Actual results may differ from these
estimates under different assumptions or conditions.



OFF BALANCE SHEET ARRANGEMENTS



During the six months ended June 30, 2013,
we did not engage in any material off-balance sheet activities nor have any relationships or arrangements with unconsolidated entities
established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. Further,
we have not guaranteed any obligations of unconsolidated entities nor do we have any commitment or intent to provide additional
funding to any such entities.



31







Item 4.        Controls
and Procedures.



Evaluation of Disclosure Controls and Procedures



Management of the Company has evaluated, with
the participation of the Chief Executive Officer and Chief Financial Officer of the Company, the effectiveness of the Company's
disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended
(the "Exchange Act")) as of the end of the quarter covered by this Quarterly Report on Form 10-Q. Based on that evaluation,
the Chief Executive Officer and Chief Financial Officer of the Company have concluded, as of the end of the quarter covered by
this Quarterly Report on Form 10-Q, that our disclosure controls and procedures have not been effective for the following reason:



A deficiency was identified as the
Company's limited segregation of duties amongst the Company's employees with respect to the Company's control activities. This
deficiency is the result of the Company's limited number of employees. This deficiency may affect management's ability to determine
if errors or inappropriate actions have taken place. Management is required to apply its judgment in evaluating the cost-benefit
relationship of possible changes in our disclosure controls and procedures.



Changes in internal control over financial
reporting.



Management of the Company has also evaluated,
with the participation of the Chief Executive Officer of the Company, any change in the Company’s internal control over financial
reporting that occurred during the period covered by this Quarterly Report on Form 10-Q and determined that there was no change
in the Company’s internal control over financial reporting that has materially affected, or is reasonably likely to materially
affect, the Company’s internal control over financial reporting.



32







Part II. Other Information



Item 2.       Unregistered
Sales of Equity Securities and Use of Proceeds.



|(a) | The Company issued an aggregate of 101,033,200 shares of Class A common stock for repayment of convertible debenture and accrued interest in lieu of cash, valued at $10,103.                                                                               
|--- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|(b) | The Company issued an aggregate of 221,571,800 shares of Class A common stock for repayment of convertible debenture and accrued interest in lieu of cash, valued at $22,157.                                                                               
|(c) | The Company issued an aggregate of 160,000,000 shares of Class A common stock for repayment of convertible debenture and accrued interest in lieu of cash, valued at $16,000.                                                                               
|(d) | The Company has issued an aggregate of 43,161,290 shares of Class A common stock upon conversion of 6,690 shares of Convertible Preferred Shares with Southridge Partners pursuant to the terms of the Equity Purchase Agreement finalized on July 16, 2012.
|(e) | The Company issued 2,200,000,000 shares of Class A common stock to Mr. Glynn as repayment of $88,000 of deferred compensation and accrued interest that Mr. Glynn earned in 2009, 2010 and 2011.                                                            



Item 3.       Defaults
Upon Senior Securities.



On March 6, 2013, the Company defaulted on
the ATG, Inc note and as such, the default interest will increase to 24.99% retroactive to the inception of the agreement..





Item 6.       Exhibits



|31.1 |  | Rule 13a-14(a)/15d-14(a) Certification.                                                                                                                                      
|---- |  | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|31.2 |  | Rule 13a-14(a)/15d-14(a) Certification.                                                                                                                                      
|32.1 |  | Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.







|101.INS |  | XBRL Instances Document*                                
|------- |  | --------------------------------------------------------
|101.SCH |  | XBRL Taxonomy Extension Schema Document*                
|101.CAL |  | XBRL Taxonomy Extension Calculation Linkbase Document*  
|101.DEF |  | XBRL Taxonomy Extension Definition Linkbase Document*   
|101.LAB |  | XBRL Taxonomy Extension Label Linkbase Document*        
|101.PRE |  | XBRL Taxonomy Extension Presentation Linkbase Document *

______________



|* |  | Pursuant to Rule 406T of
Regulation S-T, these interactive data files are not deemed filed or part of a registration statement or prospectus for purposes
of Section 11 or 12 of the Securities Act or Section 18 of the Securities Exchange Act and otherwise not subject to liability
|- |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------





33







SIGNATURES



In accordance with Section 13 or 15(d) of the
Securities Exchange Act of 1934, the Registrant caused this report on Form 10-Q to be signed on its behalf by the undersigned,
thereunto duly authorized.





|Kenergy Scientific, Inc.         | September 16, 2013
|-------------------------------- | ------------------
|                                 |                   
|By:     /s/
    Zoran Cvetojevic |                   
|Zoran Cvetojevic                 |                   
|Interim Chief Executive Officer  |                   







Pursuant to the requirements of the Securities Exchange Act of 1934,
this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.





|                                 |                   
|-------------------------------- | ------------------
|By:     /s/
    Zoran Cvetojevic | September 16, 2013
|Zoran Cvetojevic                 |                   
|Interim Chief Executive Officer  |                   







34





INDEX OF EXHIBITS



|31.1 |  | Rule 13a-14(a)/15d-14(a) Certification.                                                                                                                                      
|---- |  | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|31.2 |  | Rule 13a-14(a)/15d-14(a) Certification.                                                                                                                                      
|32.1 |  | Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.



|101.INS |  | XBRL Instances Document*                                
|------- |  | --------------------------------------------------------
|101.SCH |  | XBRL Taxonomy Extension Schema Document*                
|101.CAL |  | XBRL Taxonomy Extension Calculation Linkbase Document*  
|101.DEF |  | XBRL Taxonomy Extension Definition Linkbase Document*   
|101.LAB |  | XBRL Taxonomy Extension Label Linkbase Document*        
|101.PRE |  | XBRL Taxonomy Extension Presentation Linkbase Document *

______________



|* |  | Pursuant to Rule 406T of
Regulation S-T, these interactive data files are not deemed filed or part of a registration statement or prospectus for purposes
of Section 11 or 12 of the Securities Act or Section 18 of the Securities Exchange Act and otherwise not subject to liability
|- |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



35